Numata Sanae, Nakamura Yasuhiro, Imamura Yutaka, Honda Junichi, Momosaki Seiya, Kojiro Masamichi
First Department of Pathology, Kurume University School of Medicine, Kurume-shi, Fukuoka, Japan.
Arch Pathol Lab Med. 2005 Feb;129(2):200-4. doi: 10.5858/2005-129-200-RQAOHC.
Human cytomegalovirus (CMV) infection is a progressive and life-threatening complication in immunocompromised patients even now. Therefore, early and accurate treatment based on rapid and certain detection is needed to prevent fatal CMV infection diseases.
To study a quicker, simpler, and less expensive method of quantitative analysis using real-time polymerase chain reaction based on the SYBR Green I method of CMV detection for appropriate treatment of CMV infection in immunocompromised patients.
We quantified 50 samples tested by direct immunoperoxidase staining of leukocytes with peroxidase-labeled monoclonal antibody (C7-HRP test), 30 samples from healthy persons, and 47 samples from 7 patients suspected of having CMV infection diseases. We used the primer set in the pp65 gene of CMV and whole blood without a preparatory process. The setting for the study was the First Department of Pathology, Kurume University School of Medicine, St Mary's Hospital, and the Gene Section of the Clinical Laboratory at St Mary's Hospital, Fukuoka, Japan.
The results obtained with this method corresponded well with conventional C7-HRP tests and demonstrated excellent reproduction. Additionally, the results were better correlated with the clinical course than were C7-HRP tests.
This method was more useful than the C7-HRP test as a rapid diagnostic test for early treatment of CMV infection. This test also demonstrated its usefulness for monitoring CMV infection during treatment using ganciclovir. Moreover, it was quicker, simpler, and cheaper than other real-time polymerase chain reaction methods.
即使在当下,人巨细胞病毒(CMV)感染在免疫功能低下的患者中仍是一种进行性且危及生命的并发症。因此,需要基于快速且确定的检测进行早期准确治疗,以预防致命的CMV感染疾病。
研究一种基于SYBR Green I法的实时聚合酶链反应进行定量分析的更快、更简单且成本更低的方法,用于免疫功能低下患者CMV感染的恰当治疗。
我们对50份通过过氧化物酶标记单克隆抗体的白细胞直接免疫过氧化物酶染色检测的样本(C7-HRP检测)、30份来自健康人的样本以及47份来自7名疑似患有CMV感染疾病患者的样本进行了定量分析。我们使用了CMV pp65基因中的引物组,且无需对全血进行预处理。研究地点为日本福冈圣玛丽医院久留米大学医学院病理一科以及圣玛丽医院临床实验室基因组。
该方法获得的结果与传统C7-HRP检测结果高度相符,且重现性良好。此外,与C7-HRP检测相比,该结果与临床病程的相关性更好。
作为CMV感染早期治疗的快速诊断检测方法,该方法比C7-HRP检测更有用。该检测还证明了其在使用更昔洛韦治疗期间监测CMV感染的有用性。此外,它比其他实时聚合酶链反应方法更快、更简单且成本更低。